Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 6.1458.39-42.31-9.02-5.11

What is the latest Working Capital/Sales ratio of SOTAC PHARMACEUTICALS ?

The latest Working Capital/Sales ratio of SOTAC PHARMACEUTICALS is 6.14 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20246.14
Mar202358.39
Mar2022-42.31
Mar2021-9.02
Mar2020-5.11

How is Working Capital/Sales of SOTAC PHARMACEUTICALS Trending?

Years Working Capital/Sales % Change
Mar2024 6.14
-89.48
Mar2023 58.39
Positive
Mar2022 -42.31
Negative
Mar2021 -9.02
Negative
Mar2020 -5.11 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare Working Capital/Sales ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹121.5 Cr -1.1% -20% -8.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,684.0 Cr 2.9% 6.4% 48.1% Stock Analytics
DIVIS LABORATORIES ₹155,935.0 Cr 0.5% -2.1% 59.2% Stock Analytics
CIPLA ₹121,639.0 Cr 2.3% 1% 20.6% Stock Analytics
DR REDDYS LABORATORIES ₹115,931.0 Cr 3.5% 15.7% 20.3% Stock Analytics
ZYDUS LIFESCIENCES ₹97,876.4 Cr -0.1% 2.3% 41.1% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-1.1%

-20%

-8.1%

SENSEX

-0.7%

-1.6%

11.1%


You may also like the below Video Courses